IMO 8400 companion diagnostic - Abbott Laboratories
Latest Information Update: 23 Nov 2015
At a glance
- Originator Abbott Laboratories
- Class Diagnostic agents
- Mechanism of Action Undefined mechanism
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity No
Highest Development Phases
- Phase I/II B cell lymphoma
Most Recent Events
- 08 May 2014 Clinical trials in B-cell lymphoma (diagnosis; in patients with the MYD88 L265P mutation) in USA (unspecified route)